For about 20 percent of patients with advanced gastric cancer, tumors overproduce a receptor protein called HER2.
ILLUSTRATION BY ERIN MOORE
ORIGINALLY PUBLISHED IN “GUT REACTION,” CURE WINTER 2009
*HER2 is also associated with breast cancer.
Related Content:
FDA Approves Biosimilars for Cancer-Related Skeletal Events
Imfinzi Plus Chemo May Improve Event-Free Survival in Gastric, GEJ Cancers
177Lu-edotreotide May Delay Progression in Neuroendocrine Tumor Subset
The Dawn of a New Era in Cancer Treatment
